Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Cannabidiol at the crossroads: panacea, placebo, or problem?
    Published on 2026-04-18
    3 months ago
  • Dopaminergic hypersensitivity of the opioid-responsive striatal–entopeduncular pathway in a rodent model of restless legs syndrome
    Published on 2026-04-17
    3 months ago
  • Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators
    Published on 2026-04-16
    3 months ago
  • Correction: Psychedelic therapeutics in psychiatric conditions
    Published on 2026-04-16
    3 months ago
  • Sex-dependent role of the ventral hippocampus, but not its projection to the medial prefrontal cortex, in a novel operant conflict-driven ethanol choice task
    Published on 2026-04-16
    3 months ago
  • Causal links among gut microbiota, immune-inflammatory and compensatory immune-regulatory systems, and schizophrenia
    Published on 2026-04-15
    3 months ago
  • Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female rats
    Published on 2026-04-15
    3 months ago
« Previous 1 … 13 14 15 16 17 … 143 Next »
Journal of Psychopharmacology
  • The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures
    Published on 2026-01-02
    7 months ago
  • The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences
    Published on 2025-12-31
    7 months ago
  • Potential use of propranolol in autism spectrum disorder: A narrative review
    Published on 2025-12-29
    7 months ago
  • Effects of ketamine enantiomers on morphine and THC subjective effects in rats
    Published on 2025-12-27
    7 months ago
  • The therapeutic readiness of probiotics in major depressive disorder: A systematic review of randomised controlled trials
    Published on 2025-12-27
    7 months ago
  • Learning as the unifying mechanism of psychedelic action
    Published on 2025-12-26
    7 months ago
  • Anti-saccade error rates are associated with somatic depressive symptoms in cocaine use disorder
    Published on 2025-12-26
    7 months ago
« Previous 1 … 13 14 15 16 17 … 150 Next »
European Neuropsychopharmacology
  • All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hong Kong
    Published on 2025-12-19
    7 months ago
  • Efficacy of xanomeline and xanomeline trospium in the treatment of cognitive impairment: A systematic review of preclinical and clinical trials
    Published on 2025-12-19
    7 months ago
  • Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study
    Published on 2025-12-18
    7 months ago
  • Ayahuasca modulation of traumatic-like fear memories requires infralimbic cortex BDNF-dependent mechanisms in rats
    Published on 2025-12-18
    7 months ago
  • Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial
    Published on 2025-12-15
    7 months ago
  • Are cell type-specific methylation profiles the missing link in ADHD epigenetics?
    Published on 2025-12-14
    8 months ago
  • Dynamic functional network connectivity impairment in bipolar disorder and its relationship with global functioning
    Published on 2025-12-13
    8 months ago
« Previous 1 … 13 14 15 16 17 … 168 Next »

   Pharma Pub